N22921
yx66h02.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:266739 3', mRNA sequence.
478
mRNA
Homo sapiens
LF830077
JP 2016528161-A/22910: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
HZ527702
JP 2016501039-A/22921: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
FU797402
JP 2009528046-A/22919: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
DJ526721
JP 2010517930-A/22921: Method of constructing and screening libraries of peptide structures.
22
PRT
synthetic construct
HW858145
JP 2015051004-A/22873: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DD549524
JP 2004508801-A/22921: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
DM797379
JP 2014068652-A/22921: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
MC551421
JP 2019525738-A/22921: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
11
PRT
synthetic construct
LF682142
JP 2016521556-A/22921: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
MB812179
JP 2019502674-A/22921: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
36
PRT
synthetic construct
OG659307
JP 2021500321-A/22921: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
HW187949
JP 2013102767-A/22873: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
PA527405
JP 2022502046-A/10187: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
PA393644
JP 2021533803-A/22727: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
OG752440
JP 2021120380-A/22921: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
DL613523
JP 2011092200-A/22921: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
PD710835
JP 2021530475-A/22917: De novo Design of Protein Switches.
61
PRT
synthetic construct
DL904665
JP 2014205669-A/22921: Method of constructing and screening libraries of peptide structures.
22
PRT
synthetic construct
DJ152301
JP 2007228956-A/22919: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MD755163
JP 2019507579-A/22921: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
LX120537
JP 2017506877-A/22919: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
MD269054
JP 2020517247-A/22921: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
MC775031
JP 2018525446-A/22921: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
34
PRT
synthetic construct
DL031935
JP 2005512499-A/22921: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
1063
DNA
synthetic construct
HV879462
JP 2010507387-A/22873: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
LV568743
JP 2017029159-A/22921: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA338569
JP 2021522188-A/22921: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
DM759615
JP 2014079248-A/22921: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
LZ128429
JP 2017513485-A/22566: CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY.
18
RNA
synthetic construct